AYOXXA signs research agreement

The collaboration is the initial phase of a multi-study plan between AYOXXA and its pharmaceutical partner to collaborate in the field of ophthalmology. In a first step, AYOXXA will leverage its proprietary multiplex immunoassay platform to develop specific in vitroassays in collaboration with the partner’s research and development team. The assays will be used in clinical studies with multiple patient cohorts to identify and validate molecular biomarkers to supporting the company’s drug development efforts in ophthalmology. Read more here.